Filtros de búsqueda

Lista de obras de

Adenosine and inosine exert cytoprotective effects in an in vitro model of liver ischemia-reperfusion injury

artículo científico publicado en 2012

Cell-based screening identifies paroxetine as an inhibitor of diabetic endothelial dysfunction

artículo científico publicado en 2012

Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress ⬇️

artículo científico publicado el 16 de diciembre de 2011

Cystathionine-beta-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approach.

artículo científico publicado en 2016

Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis

artículo científico publicado en 2009

Development of a stretch-induced neurotrauma model for medium-throughput screening in vitro: identification of rifampicin as a neuroprotectant.

artículo científico publicado en 2016

Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function

artículo científico publicado en 2011

Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia

artículo científico publicado en 2011

Identification of pharmacological modulators of HMGB1-induced inflammatory response by cell-based screening

artículo científico publicado en 2013

Modulation of poly(ADP-ribose) polymerase-1 (PARP-1)-mediated oxidative cell injury by ring finger protein 146 (RNF146) in cardiac myocytes

artículo científico publicado en 2014

Oxidant-induced cardiomyocyte injury: identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay.

artículo científico publicado en 2007

Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of

scientific article published on 10 August 2016

The HIV protease inhibitor saquinavir inhibits HMGB1 driven inflammation by targeting the interaction of cathepsin V with TLR4/MyD88

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda